The Trial Begins | About | CDC

In 2008, CDC malaria expert Dr. Mary Hamel learned that the Malaria Vaccine Institute was looking for leading research institutions in Africa to conduct Phase III clinical trials of the world’s most advanced malaria candidate vaccine, RTS,S/AS01. Recognizing that CDC’s nearly 30 years of collaboration on malaria research with the Kenya Medical Research Institute (KEMRI), would uniquely qualify it for serving as vaccine trial site, she told herself: 'We must apply.'


Media Type: Html

Tags

General: prevention science CDC saving lives health threats protecting people saving money secure nation US federal agency healthy choice Mine safety black lung

Preview   0 Users liked this content.

Embed Code Snippet


To get the embed code snippet please Login.